Literature DB >> 10349869

A lysosomal proteinase, the late infantile neuronal ceroid lipofuscinosis gene (CLN2) product, is essential for degradation of a hydrophobic protein, the subunit c of ATP synthase.

J Ezaki1, I Tanida, N Kanehagi, E Kominami.   

Abstract

The specific accumulation of the hydrophobic protein, subunit c of ATP synthase, in lysosomes from the cells of patients with the late infantile form of neuronal ceroid lipofuscinosis (LINCL) is caused by lysosomal proteolytic dysfunction. The defective gene in LINCL (CLN2 gene) has been identified recently. To elucidate the mechanism of lysosomal storage of subunit c, antibodies against the human CLN2 gene product (Cln2p) were prepared. Immunoblot analysis indicated that Cln2p is a 46-kDa protein in normal control skin fibroblasts and carrier heterozygote cells, whereas it was absent in cells from four patients with LINCL. RT-PCR analysis indicated the presence of mRNA for CLN2 in cells from the four different patients tested, suggesting a low efficiency of translation of mRNA or the production of the unstable translation products in these patient cells. Pulse-chase analysis showed that Cln2p was synthesized as a 67-kDa precursor and processed to a 46-kDa mature protein (t(1/2) = 1 h). Subcellular fractionation analysis indicated that Cln2p is localized with cathepsin B in the high-density lysosomal fractions. Confocal immunomicroscopic analysis also revealed that Cln2p is colocalized with a lysosomal soluble marker, cathepsin D. The immunodepletion of Cln2p from normal fibroblast extracts caused a loss in the degradative capacity of subunit c, but not the beta subunit of ATP synthase, suggesting that the absence of Cln2p provokes the lysosomal accumulation of subunit c.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10349869     DOI: 10.1046/j.1471-4159.1999.0722573.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transfer.

Authors:  Lakshya Bajaj; Jaiprakash Sharma; Alberto di Ronza; Pengcheng Zhang; Aiden Eblimit; Rituraj Pal; Dany Roman; John R Collette; Clarissa Booth; Kevin T Chang; Richard N Sifers; Sung Y Jung; Jill M Weimer; Rui Chen; Randy W Schekman; Marco Sardiello
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons.

Authors:  M Koike; H Nakanishi; P Saftig; J Ezaki; K Isahara; Y Ohsawa; W Schulz-Schaeffer; T Watanabe; S Waguri; S Kametaka; M Shibata; K Yamamoto; E Kominami; C Peters; K von Figura; Y Uchiyama
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

3.  Lysosomal membrane permeability stimulates protein aggregate formation in neurons of a lysosomal disease.

Authors:  Matthew C Micsenyi; Jakub Sikora; Gloria Stephney; Kostantin Dobrenis; Steven U Walkley
Journal:  J Neurosci       Date:  2013-06-26       Impact factor: 6.167

4.  Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B.

Authors:  Sergey Ryazantsev; Wei-Hong Yu; Hui-Zhi Zhao; Elizabeth F Neufeld; Kazuhiro Ohmi
Journal:  Mol Genet Metab       Date:  2006-12-20       Impact factor: 4.797

5.  Enhanced expression of manganese-dependent superoxide dismutase in human and sheep CLN6 tissues.

Authors:  Claudia Heine; Jaana Tyynelä; Jonathan D Cooper; David N Palmer; Milan Elleder; Alfried Kohlschütter; Thomas Braulke
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

6.  Lysosomal serine protease CLN2 regulates tumor necrosis factor-alpha-mediated apoptosis in a Bid-dependent manner.

Authors:  Hélène Autefage; Virginie Albinet; Virginie Garcia; Hortense Berges; Marie-Laure Nicolau; Nicole Therville; Marie-Françoise Altié; Catherine Caillaud; Thierry Levade; Nathalie Andrieu-Abadie
Journal:  J Biol Chem       Date:  2009-02-26       Impact factor: 5.157

7.  Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis.

Authors:  Dolan Sondhi; Linda Johnson; Keith Purpura; Sebastien Monette; Mark M Souweidane; Michael G Kaplitt; Barry Kosofsky; Kaleb Yohay; Douglas Ballon; Jonathan Dyke; Stephen M Kaminksy; Neil R Hackett; Ronald G Crystal
Journal:  Hum Gene Ther Methods       Date:  2012-11-06       Impact factor: 2.396

Review 8.  The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease.

Authors:  Jill M Weimer; Elizabeth Kriscenski-Perry; Yasser Elshatory; David A Pearce
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 4.103

9.  Different molecular mechanisms involved in spontaneous and oxidative stress-induced mitochondrial fragmentation in tripeptidyl peptidase-1 (TPP-1)-deficient fibroblasts.

Authors:  Guillaume Van Beersel; Eliane Tihon; Stéphane Demine; Isabelle Hamer; Michel Jadot; Thierry Arnould
Journal:  Biosci Rep       Date:  2013-02-07       Impact factor: 3.840

10.  Analysis of NCL Proteins from an Evolutionary Standpoint.

Authors:  Neda E Muzaffar; David A Pearce
Journal:  Curr Genomics       Date:  2008-04       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.